Connect with us

Hi, what are you looking for?

Jewish Business News

Money

Jim Cramer: Rite Aid’s Performance Is Unacceptable

Jim Cramer

 

 

Jim Cramer has been bullish on Rite Aid for (RAD) for some time on the prospect that it will turn around its business by revamping its stores. It demonstrated that locations that had a facelift generated much more traffic. However, its comeback seems to have gotten up and left, at least for the time being, given the “horrendous” guidance management reported in its recent quarter.

Management discussed “unforseeable” problems in its generics business and reimbursement rates, but Cramer isn’t buying these explanations, and thinks the company should have known about them and pre-announced weakness ahead of the quarter. “This is unacceptable. To say this was not foreseeable? I want an explanation.”  Right now, Cramer prefers CVS Caremark (CVS).

ConAgra (CAG) is a company that does seem to be turning around successfully, and has gotten over headaches from its Ralcrop acquisition. Some of its formerly no-growth brands are seeing increasing sales, and Cramer prefers ConAgra to General Mills (GIS). However, the packaged goods stocks Cramer is recommending are those connected to the healthy eating trend, such as WhiteWave (WWAV) and Hain Celestial (HAIN).

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış cialis